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Abstract
I In nt tr ro od du uc ct ti io on n: :   To construct a eukaryotic expression vector of the tumour
suppressor in lung cancer 1 (TSLC1) gene, so as to explore the mechanisms of
tumour suppression of the gene theoretically.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   The open reading frame (ORF) of TSLC1 gene was
amplified with RT-PCR from normal human foreskin acrobystia, and cloned to
pMD19-T  simple  vector  (TA  Clone  method).  The  resultant  plasmid  was
transformed  into  Escherichia  coli  JM109  for  amplification.  The  TA  Clone
recombinant was digested by double restriction enzyme (Bgl II/EcoR I) and
analysed with agarose gel electrophoresis. The positive one was sequenced.
The inserted DNA fragment was recovered, and then it was mounted into the
eukaryotic expression vector pIRES2-EGFP, transformed into E. coli JM109 for
amplification. A positive recombinant plasmid named pIRES2-EGFP-TSLC1 was
confirmed by Bgl II/EcoR I double-enzyme digestion analysis.
R Re es su ul lt ts s: :   RT-PCR amplified the ORF of the TSLC1 gene. It was approximately 1400
base pairs. The obtained DNA was confirmed a high degree of homology with
the sequence of TSLC1 cDNA sequence (AY358334) stored at GenBank.
C Co on nc cl lu us si io on ns s: :    Construction  of  a TSLC1  eukaryotic  expression  vector  was
successful, and it has established a solid foundation for further study.
K Ke ey y   w wo or rd ds s: :   TSLC1 gene, construction, eukaryotic expression vector.
Introduction
Cancer is still an inextirpable disease. However, human beings have
evolved an array of host anti-tumour surveillance, to combat the arising
malignant cell clones [1]. Tumour suppressor in lung cancer 1 (TSLC1) is
a cloned tumour suppressor gene [2-5]. It is expressed in a variety of
tissues and organs in the human body, particularly in the normal lung,
brain, liver and skin tissues [6], but silenced in many cancers such as larynx
cancer [7], cervical cancer [8], breast [9] and nasopharyngeal cancer [10].
It is widely considered to play a negative role in tumour genesis and
development. Mao et al. [11] transfected recombinant adenovirus encoding
TSLC1 cDNA into non-small cell lung cancer (NSCLC) A549 cell line, and
found that 60% of cells underwent apoptosis as TSLC1 accumulated, and
induced the activation of caspase 3 at the same. The suppressive role of
TSLC1 in genesis and progression of tumours is not fully understood, but
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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available  data  suggest  that  it  regulates  cell
apoptosis and the cell cycle. So far, little is known
about the effect of the TSLC1 gene on malignant
cells; therefore, we constructed the TSLC1 gene
eukaryotic expression vector, so as to establish
a solid foundation for further study.
Material and methods
Normal foreskin acrobystia was obtained from
patients admitted to Guangdong Medical College
Hospital emergency operating room with written
consent; TRIzol was purchased from Invitrogen
(Carlsbad, CA, USA); Escherichia coli JM109 and
plasmid pIRES2-EGFP were kind gifts from the
biochemistry laboratory of Guangdong Medical
College; High Fidelity PrimeScript™ RT-PCR Kit,
DL2,000  DNA  Marker,  λ-Hind  III  DNA  Marker,
pMD19-T Simple vector, DNA A-Tailing Kit, DNA
Ligation Kit, Agarose Gel DNA Purification Kit,
restriction endonucleases EcoR I and Bgl II were
purchased from TaKaRa Biotechnology Co, Ltd
(Dalian, China). Mini Plasmid Purification Kit was
obtained from Beyotime Institute of Biotechnology
(Haimen, China).
O Ob bt ta ai in ni in ng g   a an nd d   i id de en nt ti if fi ic ca at ti io on n   o of f   T TS SL LC C1 1
D De es si ig gn n   a an nd d   s sy yn nt th he es si is s   o of f   T TS SL LC C1 1   p pr ri im me er r
According to GenBank, accessible human TSLC1
gene mRNA sequence data (serial accession: AY
358334), using the primer design software Premier
5.0 to design primers containing Bgl II/EcoR I
restriction site fragment for amplification of the ORF
length of TSLC1. The primer was synthesized by
TaKaRa Biotechnology Co, Ltd (Dalian, China)
Primer: OUTER F 5’-GCGTGGGGTGCCCGACATGG-3’
20 mers 
OUTER R 5’-AAATAGGGCCAGTTGGACAC-3’ 20 mers.
T To ot ta al l   R RN NA A   e ex xt tr ra ac ct ti io on n   
Up  to  100 mg  of  the  normal  foreskin  (fat
removed)  specimen  plus  liquid  nitrogen  were
ground to powder in a grinder followed by adding
1 ml Trizol, and extraction of total RNA (according
to the instructions of the Trizol kit).
R RT T- -P PC CR R   a as ss sa ay y   
With the High Fidelity Prime Script ™ RT-PCR Kit
for  (according  to  instructions  of  the  kit)  PCR
amplification, the PCR conditions were: 94°C, 3 min,
1 cycle; 98°C, 10 s, 55°C, 15 s, 72°C, 1 min, 30 cycles;
72°C, 10 min, 1 cycle. 
R Re ec co ov ve er ry y   a an nd d   p pu ur ri if fi ic ca at ti io on n   o of f   P PC CR R   p pr ro od du uc ct t   
Take PCR products were loaded in 1 × TAE buffer
agarose gel electrophoresis, 120 V, 30 min; agarose
gel including the purpose of DNA was excised under
the UV lamp, purified using TaKaRa Agarose Gel
DNA Purification Kit according to the instructions,
and TSLC1 fragments were recovered.
T TA A   C Cl lo on ni in ng g   
One µg of the recovered TSLC1 fragments was
added “A” tail with A-Tailing Kit; 5 µl of the reaction
solution was analysed with agarose gel electro  -
phoresis; the new TSLC1 fragments were ligated to
pMD19-T Simple vector with the proportion of 9 : 1
for 16°C, 30 min; 10 µl of pMD19-T Simple-TSLC1
solution was transformed into competent E. coli
JM109 for amplification. 
E Ex xt tr ra ac ct ti io on n   a an nd d   i id de en nt ti if fi ic ca at ti io on n   o of f   p pM MD D1 19 9- -T T
s si im mp pl le e- -T TS SL LC C1 1   r re ec co om mb bi in na an nt t   p pl la as sm mi id d   
pMD19-T Simple-TSLC1 recombinant plasmid
was extracted from E. coli JM109 with Mini Plasmid
Purification Kit according to the instructions; 1 µg
of recombinant plasmid was digested by restriction
enzyme Bgl II and EcoR I for 37°C, 8 h; 5 µl of
digestion product was analysed with agarose gel
electrophoresis; the positive plasmid was sequen  -
ced  by  TaKaRa  Biotechnology  Co,  Ltd  (Dalian,
China).
S Su ub bc cl lo on ne e   o of f   p pI IR RE ES S2 2- -E EG GF FP P- -T TS SL LC C1 1   r re ec co om mb bi in na an nt t
p pl la as sm mi id d   
R Re ec co ov ve er ry y   o of f   T TS SL LC C1 1
Double restriction enzymes (Bgl II and EcoR I)
digested  pMD19-T  Simple-TSLC1  recombinant
plasmid, and the remaining steps were the same
as “Recovery and purification of PCR product”.
L Li ig ga at ti io on n   o of f   p pI IR RE ES S2 2- -E EG GF FP P- -T TS SL LC C1 1
The recovered TSLC1 fragment was inserted to
pIRES2-EGFP  vector  with  the  concentration
proportion of 9 : 1 for 16°C, 8 h (according to DNA
Ligation Kit instructions), and then transformed into
competent E. coli JM 109 for amplification.
E Ex xt tr ra ac ct ti io on n   a an nd d   i id de en nt ti if fi ic ca at ti io on n   o of f   p pI IR RE ES S2 2- -E EG GF FP P- -
T TS SL LC C1 1   r re ec co om mb bi in na an nt t   p pl la as sm mi id d
This  step  is  the  same  as  “Extraction  and
identification of pMD19-T simple-TSLC1 recom  -
binant” except for DNA sequencing. 
Results
E Ev va al lu ua at ti io on n   o of f   R RT T- -P PC CR R   p pr ro od du uc ct t
The total RNA extracted from normal foreskin
tissue  was  reversely  transcribed  to  cDNA  as
a template for PCR, and the full length of 1400 bp
of TSLC1 was obtained. Figure 1 depicts the resultArch Med Sci 4, August / 2011 581
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of purification of the TSLC1 gene fragment after
adding the "A" tail. Figures 2 and 3 show the basic
structure and restriction sites of plasmid pMD19-T
Simple and pIRES2-EGFP respectively. 
E Ev va al lu ua at ti io on n   o of f   T TA A   C Cl lo on ne e   r re ec co om mb bi in na an nt t   p pl la as sm mi id d
pMD19-T Simple-TSLC1 recombinant plasmid was
digested by restriction enzymes Bgl II and EcoR I and
analysed with agarose gel electrophoresis. The
positive plasmid was sequenced. The result is
shown in Figure 4. Obtained data were aligned with
the sequences deposited in GenBank (AY 358334).
E Ev va al lu ua at ti io on n   o of f   p pI IR RE ES S2 2- -E EG GF FP P- -T TS SL LC C1 1   r re ec co om mb bi in na an nt t
p pl la as sm mi id d
pIRES2-EGFP-TSLC1 recombinant plasmid was
digested by restriction enzymes Bgl II and EcoR I,
and then analysed together with pIRES2-EGFP
vector (after being digested by restriction enzymes
Bgl II and EcoR I) and TSLC1 (from “Recovery of
TSLC1”) recovered with agarose gel electrophoresis
(Figure 5). The result confirmed that the pIRES2-
EGFP-TSLC1  eukaryotic  expression  vector  was
successfully constructed.
Discussion
Since identification of TSLC1, many scholars have
found that it was low or missing expression in
a variety of human cancer tissues, while widely
present in normal human tissues, especially in the
skin, lungs and liver tissues. Therefore, TSLC1 is
widely considered as a tumour suppressor gene.
The gene has been a hot spot in cancer research,
especially the mechanisms of potential to induce
apoptosis in malignant cells. In this study, extracts
from skin and constructs TSLC1 gene eukaryotic
F Fi ig gu ur re e   1 1. .   Purification of the TSLC1 gene fragment
M – DL2.000 DNA marker, 1 – TSLC1-PCR product (added “A”
tail)
F Fi ig gu ur re e   2 2. .   The structure and important restriction sites of pMD19-T simple vector 
M                                             1
BcaBESTTM sequencing primer RV-M
GAGCGGATAACAATTTCACACAGG
IacZ EcoRV
5’  GAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGCCAAGTTTGCACGCCTGCCGTTCGACGACGATATCTCTGGAAGATCCGCGCGTACCGAGTTCTAATTC
ACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCG  3’   Digested by EcoR V
CAGCACTGACCCTTTGGGACCGC   
BceBESTTM sequencing primer M13-47
…ttcgacgatT atctctgga…  
…aagctgcta Ttagagacct…
EcoR V               T-cloning site
Amp r
IacZ
ori
O
pMDTM19-T
simple vector 
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591 601 611 621 631 641 651 661
•• ••• • • •
GCTAGCGCTACCGGACTCAGATCTCGAGCTCAAGCTTCGAATTCTGCAGTCGACGGTACCGCGGGCCCGGGATCC... I IR RE ES S
Nhe I Eco47 III Bgl II
Sac I
Ecl136 II
Hind III EcoR I Pst I Sal I
Acc I
Kpn I
Asp718 I Apa I
Bsp120 I
Sac II Xma I
Sma I BamH I
Xho I
p pI IR RE ES S2 2- -E EG GF FP P   
5 5. .3 3   k kb b
p pI IR RE ES S2 2- -E EG GF FP P   v ve ec ct to or r   i in nf fo or rm ma at ti io on n PT3267-5
Catalog #6029-1
pUC 
ori
HSV TK
poly A
PCMV IE
P
SV40 ori  
P 
SV40e
Kanr/Neor
IRES
MCS (591-666)
EGFP
SV40
poly A
f1 
ori
F Fi ig gu ur re e   3 3. . The structure and digestion sites of pIRES2-EGFP plasmid
F Fi ig gu ur re e   4 4. . Full-length 1393 bp of the TSLC1 gene sequence diagramArch Med Sci 4, August / 2011 583
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expression  vector  for  further  study  of  the
mechanism of tumour suppressor genes.
The key of the TSLC1 gene clone is the vector; it
determines  whether  the  exogenous  gene  can
express steadily after being transfected into cells.
The present study shows that the pIRES2-EGFP
eukaryotic expression vector has the following
advantages: 1) It contains internal ribosome entry
site 2 (IRES2) and enhanced green fluorescent
protein (EGFP) clone regions, enable transiently
transfected into mammalian cells to express EGFP
with high selectivity; furthermore, it is able not only
to express EGFP alone but also to obtain a stable
transfected cell line. 2) The EGFP is a kind of wild-
type GFP, with characteristics of highly selective
fluorescence and highly expressed in mammalian
cells. Two amino acids (Phe-64 and Ser-65) in GFP
mut1 variant6 of EGFP can be replaced by Leu and
Thr, which makes its green fluorescence intensity
increase greatly, thus screening exogenous gene
expression in mammalian cells easily. 3) It contains
an  immediate  early  strong  promoter  from
cytomegalovirus, which is conducive to a high level
of  transcription;  furthermore,  the  EGFP  gene
downstream contains SV40 polyA signal, which can
improve the stability of RNA. 4) It contains the
neomycin and kanamycin resistance gene and the
HSV TK gene poly A signal, which are favourable to
screening positive cells after cell transformation or
transfection [12-14]. 
Designing a pair of primers with Bgl II/EcoR I
restriction enzyme sites to amplify the ORF of
TSLC1, and mounted to pMD19-T Simple vector,
E.  coli  transformation,  sequencing,  etc.,  have
confirmed that the obtained cDNA extracted from
the skin is submitted to GenBank release (accession
number: AY 358334). In the current study, this DNA
Ligation Kit is different from the ordinary Taq ligase
enzyme, which can ligate the TSLC1 fragment into
the  pIRES2-EGFP  eukaryotic  expression  vector
exactly  and  efficiently  after  double  restriction
enzyme digestion, without needing to consider the
pros and cons ends of ligating fragments. The
recombinant plasmid was excised out by Bgl II/
EcoR I double-restriction enzyme digestion and
analysed by agarose gel electrophoresis. The result
shows that the ligated fragments were about 1.4 kb
and 5.3 kb, which reveals that the TSLC1 gene and
pIRES2-EGFP vector size was corrected, and the
TSLC1  eukaryotic  expression  vector  has  been
constructed successfully.
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